Redox-Related Genetic and Biological Ageing Signals in Rapid Pain Progression of Knee Osteoarthritis: A Hypothesis-Generating Analysis in the Osteoarthritis Initiative

Rapid pain progression in knee osteoarthritis (OA) is heterogeneous and may reflect redox-related mechanisms. We performed an exploratory analysis in Osteoarthritis Initiative (OAI) participants, combining nuclear genome-wide association, mitochondrial DNA (mtDNA) haplogroups, and leukocyte telomere length. Rapid pain progression was defined using the rescaled Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) for pain (0-100) within 24-month windows. An additive genome-wide association study (GWAS) in 2946 participants tested 7,762,204 imputed variants, adjusting for age, sex, body mass index (BMI) and three principal components. Haplogroups were analysed in 3357 participants, and telomere length (telomere-to-single-copy gene, T/S, ratio) was analysed in 301 participants. No variant reached genome-wide significance (<i>p</i> < 5 × 10<sup>-8</sup>), but six loci were suggestive (<i>p</i> < 5 × 10<sup>-6</sup>), with minimal inflation (λ = 0.995). mtDNA haplogroup H was nominally associated with rapid pain progression (odds ratio, OR = 1.179, <i>p</i> = 0.023). Rapid pain progressors had shorter baseline telomeres (0.825 ± 0.268 vs. 0.985 ± 0.375; <i>p</i> < 0.001), and telomere length was inversely associated with progression (OR per 1-unit T/S = 0.260, <i>p</i> = 0.007). These preliminary, hypothesis-generating findings are compatible with a redox-related interpretation of rapid pain progression and require external validation in independent cohorts, while providing candidates for future mechanistic studies.

Authors

Institutions

Publication Details

Journal
Antioxidants
Published
2026-02-21
DOI
https://doi.org/10.3390/antiox15020266
Primary Topic
Osteoarthritis Treatment and Mechanisms
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Redox-Related Genetic and Biological Ageing Signals in Rapid Pain Progression of Knee Osteoarthritis: A Hypothesis-Generating Analysis in the Osteoarthritis Initiative

N. Oreiro, Jorge Vázquez-García, S. Relaño, Antonio Morano-Torres et al.
Antioxidants
Osteoarthritis Treatment and Mechanisms
article

Redox-Related Genetic and Biological Ageing Signals in Rapid Pain Progression of Knee Osteoarthritis: A Hypothesis-Generating Analysis in the Osteoarthritis Initiative

N. Oreiro, Jorge Vázquez-García, S. Relaño, Antonio Morano-Torres, Ignacio Rego-Perez, Alejandro Mosquera, Laura Martínez-Sotodosos, Diana M. Noriega-Cobo, Fátima Otero-Fariña, Francisco J. Blanco, Jose L. Fernández
article en

Abstract

Rapid pain progression in knee osteoarthritis (OA) is heterogeneous and may reflect redox-related mechanisms. We performed an exploratory analysis in Osteoarthritis Initiative (OAI) participants, combining nuclear genome-wide association, mitochondrial DNA (mtDNA) haplogroups, and leukocyte telomere length. Rapid pain progression was defined using the rescaled Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) for pain (0-100) within 24-month windows. An additive genome-wide association study (GWAS) in 2946 participants tested 7,762,204 imputed variants, adjusting for age, sex, body mass index (BMI) and three principal components. Haplogroups were analysed in 3357 participants, and telomere length (telomere-to-single-copy gene, T/S, ratio) was analysed in 301 participants. No variant reached genome-wide significance (<i>p</i> < 5 × 10<sup>-8</sup>), but six loci were suggestive (<i>p</i> < 5 × 10<sup>-6</sup>), with minimal inflation (λ = 0.995). mtDNA haplogroup H was nominally associated with rapid pain progression (odds ratio, OR = 1.179, <i>p</i> = 0.023). Rapid pain progressors had shorter baseline telomeres (0.825 ± 0.268 vs. 0.985 ± 0.375; <i>p</i> < 0.001), and telomere length was inversely associated with progression (OR per 1-unit T/S = 0.260, <i>p</i> = 0.007). These preliminary, hypothesis-generating findings are compatible with a redox-related interpretation of rapid pain progression and require external validation in independent cohorts, while providing candidates for future mechanistic studies.

AntioxidantsVol. 15(2)
Universidade da Coruña (ES), Centro Oncológico de Galicia (ES), Instituto de Investigación Biomédica de A Coruña (ES)
U.S. Department of Health and Human Services, Eli Lilly and Company, Pfizer, GlaxoSmithKline, Novartis Pharmaceuticals Corporation, European Commission, Axencia Galega de Innovación, Xunta de Galicia, National Institutes of Health, Instituto de Salud Carlos III, Servicio Gallego de Salud
Openalex Percentile: Top 49%
Osteoarthritis Treatment and Mechanisms
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.